ALPMF
Price
$9.61
Change
-$0.50 (-4.95%)
Updated
Jun 24 closing price
Capitalization
26.55B
AZNCF
Price
$140.69
Change
-$3.20 (-2.22%)
Updated
Jul 3 closing price
Capitalization
222.83B
Interact to see
Advertisement

ALPMF vs AZNCF

Header iconALPMF vs AZNCF Comparison
Open Charts ALPMF vs AZNCFBanner chart's image
Astellas Pharma
Price$9.61
Change-$0.50 (-4.95%)
Volume$4.1K
Capitalization26.55B
AstraZeneca
Price$140.69
Change-$3.20 (-2.22%)
Volume$1.4K
Capitalization222.83B
ALPMF vs AZNCF Comparison Chart in %
Loading...
ALPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AZNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALPMF vs. AZNCF commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMF is a Hold and AZNCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (ALPMF: $9.60 vs. AZNCF: $140.68)
Brand notoriety: ALPMF and AZNCF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMF: 191% vs. AZNCF: 55%
Market capitalization -- ALPMF: $26.55B vs. AZNCF: $222.83B
ALPMF [@Pharmaceuticals: Major] is valued at $26.55B. AZNCF’s [@Pharmaceuticals: Major] market capitalization is $222.83B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMF’s FA Score shows that 1 FA rating(s) are green whileAZNCF’s FA Score has 1 green FA rating(s).

  • ALPMF’s FA Score: 1 green, 4 red.
  • AZNCF’s FA Score: 1 green, 4 red.
According to our system of comparison, AZNCF is a better buy in the long-term than ALPMF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMF’s TA Score shows that 3 TA indicator(s) are bullish while AZNCF’s TA Score has 3 bullish TA indicator(s).

  • ALPMF’s TA Score: 3 bullish, 5 bearish.
  • AZNCF’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ALPMF is a better buy in the short-term than AZNCF.

Price Growth

ALPMF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while AZNCF (@Pharmaceuticals: Major) price change was +0.54% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZNCF($223B) has a higher market cap than ALPMF($26.6B). ALPMF has higher P/E ratio than AZNCF: ALPMF (39.22) vs AZNCF (36.10). AZNCF YTD gains are higher at: 8.219 vs. ALPMF (-2.586). ALPMF has higher annual earnings (EBITDA): 247B vs. AZNCF (12.9B). ALPMF has more cash in the bank: 397B vs. AZNCF (5.81B). AZNCF (29.8B) and ALPMF (30B) have identical debt. ALPMF has higher revenues than AZNCF: ALPMF (1.52T) vs AZNCF (44.5B).
ALPMFAZNCFALPMF / AZNCF
Capitalization26.6B223B12%
EBITDA247B12.9B1,915%
Gain YTD-2.5868.219-31%
P/E Ratio39.2236.10109%
Revenue1.52T44.5B3,413%
Total Cash397B5.81B6,831%
Total Debt30B29.8B101%
FUNDAMENTALS RATINGS
ALPMF vs AZNCF: Fundamental Ratings
ALPMF
AZNCF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
23
Undervalued
PROFIT vs RISK RATING
1..100
10053
SMR RATING
1..100
10046
PRICE GROWTH RATING
1..100
6158
P/E GROWTH RATING
1..100
9881
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMF's Valuation (8) in the null industry is in the same range as AZNCF (23). This means that ALPMF’s stock grew similarly to AZNCF’s over the last 12 months.

AZNCF's Profit vs Risk Rating (53) in the null industry is somewhat better than the same rating for ALPMF (100). This means that AZNCF’s stock grew somewhat faster than ALPMF’s over the last 12 months.

AZNCF's SMR Rating (46) in the null industry is somewhat better than the same rating for ALPMF (100). This means that AZNCF’s stock grew somewhat faster than ALPMF’s over the last 12 months.

AZNCF's Price Growth Rating (58) in the null industry is in the same range as ALPMF (61). This means that AZNCF’s stock grew similarly to ALPMF’s over the last 12 months.

AZNCF's P/E Growth Rating (81) in the null industry is in the same range as ALPMF (98). This means that AZNCF’s stock grew similarly to ALPMF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMFAZNCF
RSI
ODDS (%)
Bullish Trend 3 days ago
53%
Bearish Trend 3 days ago
53%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
54%
Bullish Trend 3 days ago
68%
Momentum
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
57%
MACD
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
49%
Bearish Trend 3 days ago
57%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
65%
Declines
ODDS (%)
N/A
Bearish Trend 9 days ago
50%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
47%
Aroon
ODDS (%)
Bullish Trend 3 days ago
54%
Bullish Trend 3 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
ALPMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AZNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SITIY34.592.30
+7.12%
SITC International Holdings Company, Ltd.
KINS15.650.47
+3.10%
Kingstone Companies
SCS11.250.03
+0.27%
Steelcase
NTXVF0.62N/A
N/A
Nexteer Automotive Group Ltd.
LXRX0.90-0.01
-1.63%
Lexicon Pharmaceuticals

ALPMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMF has been loosely correlated with ALPMY. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMF jumps, then ALPMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMF
1D Price
Change %
ALPMF100%
N/A
ALPMY - ALPMF
40%
Loosely correlated
-0.52%
AZNCF - ALPMF
7%
Poorly correlated
-2.22%
GRFS - ALPMF
4%
Poorly correlated
-0.66%
JNJ - ALPMF
2%
Poorly correlated
N/A
BAYRY - ALPMF
-1%
Poorly correlated
-1.16%
More

AZNCF and

Correlation & Price change

A.I.dvisor tells us that AZNCF and BAYRY have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AZNCF and BAYRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZNCF
1D Price
Change %
AZNCF100%
-2.22%
BAYRY - AZNCF
20%
Poorly correlated
-1.16%
AZN - AZNCF
16%
Poorly correlated
-2.36%
ABBV - AZNCF
9%
Poorly correlated
-0.77%
ALPMY - AZNCF
9%
Poorly correlated
-0.52%
ALPMF - AZNCF
7%
Poorly correlated
N/A
More